Intro

This chapter reviews a research study on the impact of reducing antipsychotic medication in stable schizophrenia patients, revealing an increase in hospitalizations rather than improvement in social functioning. It also discusses the study's limitations, particularly the short duration and effects of COVID-19 on assessments.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.